Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
Author:
Publisher
Baishideng Publishing Group Inc.
Reference67 articles.
1. AASLD guidelines for the treatment of hepatocellular carcinoma
2. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
4. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
5. Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Commentary on “Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness”;CardioVascular and Interventional Radiology;2024-06-24
2. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases;Medicine;2024-05-17
3. New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma;Chinese Journal of Cancer Research;2024
4. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy;Nature Reviews Clinical Oncology;2023-10-26
5. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment;Clinical and Molecular Hepatology;2023-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3